ArticleCell death discovery2021

The JAK2 inhibitor TG101209 exhibits anti-tumor and chemotherapeutic sensitizing effects on Burkitt lymphoma cells by inhibiting the JAK2/STAT3/c-MYB signaling axis.

Yang Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.